DERIVATIVES - Schedule of Derivative Instrument Presented on Consolidated Balance Sheets and Notional Amount (Details) - USD ($) $ / shares in Units, $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Warrant Liability | $ 5,820 | $ 7,624 |
| Derivatives Not Designated as Hedging Instruments | Penny Warrants | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Number of Warrants (in shares) | 12,024,711 | 12,024,711 |
| Warrant Liability | $ 7,624 | |
| Exercise Price Per Share (in dollars per share) | $ 0.05 | $ 0.05 |
| X | ||||||||||
- Definition Warrant Liability, Current No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|